AAPM Task Group 198 Report: An implementation guide for TG 142 quality assurance of medical accelerators

DOI Web Site Web Site Web Site 被引用文献6件
  • Joseph Hanley
    Princeton Radiation Oncology Monroe New Jersey 08831 USA
  • Sean Dresser
    Winship Cancer Institute, Radiation Oncology Emory University Atlanta Georgia 30322 USA
  • William Simon
    Sun Nuclear Corp Melbourne Florida 32940 USA
  • Ryan Flynn
    Department of Radiation Oncology University of Iowa Iowa City, Iowa 52242 USA
  • Eric E. Klein
    Brown university Rhode Island Hospital Providence Rhode Island 02905 USA
  • Daniel Letourneau
    Princess Margaret Cancer Centre Toronto M5G 2M9 Canada
  • Chihray Liu
    University of Florida Gainesville Florida 32610‐0385 USA
  • Fang‐Fang Yin
    Department of Radiation Oncology Duke University Medical Center Durham North Carolina 27710 USA
  • Bijan Arjomandy
    Karmanos Cancer Institute at McLaren‐Flint Flint Michigan 48532 USA
  • Lijun Ma
    Department of Radiation Oncology University of California San Francisco San Francisco 94143‐0226 USA
  • Francisco Aguirre
    MD Anderson Cancer Center Mansfield OH 44907 USA
  • Jimmy Jones
    Department of Radiation Oncology The University of Colorado Health—Poudre Valley Fort Collins Colorado 80525 USA
  • John Bayouth
    Department of Human Oncology School of Medicine and Public Health University of Wisconsin—Madison Madison Wisconsin 53792‐0600 USA
  • Todd Holmes
    Varian Medical Systems Palo Alto California 94304 USA

抄録

<jats:p>The charges on this task group (TG) were as follows: (a) provide specific procedural guidelines for performing the tests recommended in TG 142; (b) provide estimate of the range of time, appropriate personnel, and qualifications necessary to complete the tests in TG 142; and (c) provide sample daily, weekly, monthly, or annual quality assurance (QA) forms. Many of the guidelines in this report are drawn from the literature and are included in the references. When literature was not available, specific test methods reflect the experiences of the TG members (e.g., a test method for door interlock is self‐evident with no literature necessary). In other cases, the technology is so new that no literature for test methods was available. Given broad clinical adaptation of volumetric modulated arc therapy (VMAT), which is not a specific topic of TG 142, several tests and criteria specific to VMAT were added.</jats:p>

収録刊行物

被引用文献 (6)*注記

もっと見る

問題の指摘

ページトップへ